Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids.-Reference-Cited by-同舟云学术

Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids.

Published:1987-11-14 Issue:6608 Volume:295 Page:1227-1229
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Henry D A,Johnston A,Dobson A,Duggan J

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference12 articles.

1. Peptic ulcer complications and the use of non-aspirin non-steroidal antiinflammatorydrugs;Langman, M.J.S.;A DruReactionliullean,1986

2. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer;Somerville, K.; Faulkner, G.; Langmsan, M.J.S.;Lancet,1986

3. Ulcer perforation in the elderly and non-steroidal anti-inflammatory drugs;Blower, A.L.; Armstrong, C.P.;Lancet,1986

4. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration;Armstrong, C.P.; Blower, A.L.;Gut,1987

5. National ASGE survey on upper gastrointestinal bleeding-Multivariate analysis of predictors ofoutcome;Gilbert, D.A.; Persing, J.; Silverstein, F.E.;GasmntestEndosc,1982

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DENTAL USE OF KETOROLAC TROMETHAMINE: STATUS AND FUTURE PERSPECTIVES;International Journal of Applied Pharmaceutics;2023-03-07

2. Systemic Corticosteroids;Comprehensive Dermatologic Drug Therapy;2021

3. Empirical assessment of case‐based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database ( SNDS );Pharmacoepidemiology and Drug Safety;2020-06-10

4. NSAIDs as a Cause of Morbidity and Mortality from Peptic Ulcer Complications in New South Wales;Pharmacoepidemiology;2018-12-19

5. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs;Annals of the Rheumatic Diseases;2016-07-12